Bio-Path Holdings Inc (BPTH)
2.65
-0.03
(-1.12%)
USD |
NASDAQ |
May 03, 16:00
2.65
0.00 (0.00%)
After-Hours: 20:00
Bio-Path Holdings 1 Year Total Returns (Daily): -90.36% for May 2, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 02, 2024 | -90.36% |
May 01, 2024 | -90.35% |
April 30, 2024 | -89.96% |
April 29, 2024 | -89.89% |
April 26, 2024 | -89.02% |
April 25, 2024 | -90.24% |
April 24, 2024 | -90.98% |
April 23, 2024 | -90.41% |
April 22, 2024 | -89.57% |
April 19, 2024 | -85.16% |
April 18, 2024 | -84.89% |
April 17, 2024 | -88.34% |
April 16, 2024 | -89.03% |
April 15, 2024 | -89.42% |
April 12, 2024 | -89.62% |
April 11, 2024 | -89.21% |
April 10, 2024 | -88.23% |
April 09, 2024 | -86.55% |
April 08, 2024 | -86.30% |
April 05, 2024 | -84.86% |
April 04, 2024 | -84.64% |
April 03, 2024 | -84.63% |
April 02, 2024 | -84.77% |
April 01, 2024 | -83.45% |
March 28, 2024 | -87.44% |
Date | Value |
---|---|
March 27, 2024 | -87.45% |
March 26, 2024 | -87.20% |
March 25, 2024 | -87.96% |
March 22, 2024 | -86.04% |
March 21, 2024 | -86.10% |
March 20, 2024 | -85.20% |
March 19, 2024 | -85.38% |
March 18, 2024 | -84.42% |
March 15, 2024 | -84.67% |
March 14, 2024 | -81.73% |
March 13, 2024 | -81.72% |
March 12, 2024 | -79.96% |
March 11, 2024 | -81.25% |
March 08, 2024 | -82.23% |
March 07, 2024 | -81.01% |
March 06, 2024 | -81.06% |
March 05, 2024 | -82.07% |
March 04, 2024 | -82.30% |
March 01, 2024 | -83.01% |
February 29, 2024 | -83.20% |
February 28, 2024 | -83.34% |
February 27, 2024 | -86.34% |
February 26, 2024 | -83.98% |
February 23, 2024 | -84.17% |
February 22, 2024 | -80.64% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-90.98%
Minimum
Apr 24 2024
317.1%
Maximum
Jan 21 2020
-30.67%
Average
-51.30%
Median
1 Year Total Returns (Daily) Benchmarks
INVO Bioscience Inc | -86.89% |
EyePoint Pharmaceuticals Inc | 207.1% |
Hepion Pharmaceuticals Inc | -88.69% |
Aileron Therapeutics Inc | 176.5% |
Protara Therapeutics Inc | -8.25% |